Fangzhou Inc. (6086.HK)
HKSE · HKD · Healthcare · Pharmaceutical Retailers
HK$0.915 (+0.55%) as of
Key statistics
- Market cap
- 1.27B
- P/E (TTM)
- 91.50
- Forward P/E
- 12.84
- EPS (TTM)
- 0.010
- Dividend yield
- 0.00%
- 52-week range
- 0.625 – 4.330
- Beta
- 0.53
- Revenue (TTM)
- 3.86B
- Profit margin
- 0.21%
- Analyst target
- HK$6.05
- Volume
- 22.00k
About Fangzhou Inc.
Fangzhou Inc. provides online chronic disease management services in China. It operates through four segments: Online Retail Pharmacy Services; Comprehensive Medical Services; Wholesale; and Customized Content and Marketing Solutions. The company offers services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory diseases. It also engages in the sales of pharmaceutical and healthcare products through online retail pharmacy service platform, third-party platforms, and offline retail pharmacies; and online consultation, e-prescription, physician consultation, physical examination, and surgery service, as well as wholesale of pharmaceutical products. Fangzhou Inc. was founded in 2015 and is based in Guangzhou, China.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Headquarters
- Guangzhou, China
- Employees
- 514
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.